{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:21:28Z","timestamp":1788182488424,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"\n Background:<\/jats:title>\n Although anthracycline chemotherapy is widely used in different types of cancer, they are commonly known to induce cardiotoxicity. Early diagnosis of cardiotoxicity induced by cancer therapy is of great interest. Due to the insensitivity of left ventricular ejection fraction (LVEF) in the early identification of cardiotoxicity, global longitudinal strain (GLS) has become the best approach for early cardiotoxicity identification. The goal of our research was to assess the function of the Tei Index, a relatively new tool for evaluating both diastolic and systolic function, in the prediction of cardiac dysfunction.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n One hundred patients were enrolled in our prospective observational study. Demographic and clinical data were collected at the first visit. Assessments of LVEF, GLS, and the Tei Index were taken before initiation of therapy and subsequently at 3- and 6-month intervals (2\n nd<\/jats:sup>\n and 3\n rd<\/jats:sup>\n visit, respectively) following anthracycline.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n The patients\u2019 mean age was 44.79 \u00b1 14.26 years, predominantly females (76%). The mean LVEF fell from 63.44 \u00b1 3.61 to 59.90 \u00b1 6.00 6 months following chemotherapy. At the 6-month visit, 16% patients developed evident impairment in left ventricular systolic function with LVEF below 55%. The mean GLS at the first visit was 19.94 \u00b1 2.68 and showed a significant decrease in its values to 17.27 \u00b1 2.1 6 months postchemotherapy, with 20% of patients having a percentage change in GLS \u226515% (subclinical cardiotoxicity). Mean Tei Index has been significantly increased from 0.42 \u00b1 0.09 at the first visit to 0.52 \u00b1 0.08 at the third visit. After 6 months postchemotherapy, there was a significant inverse relationship between ejection fraction (EF) and Tei Index (\n P<\/jats:italic>\n < 0.001,\n r<\/jats:italic>\n = \u22120.309); on the other hand, there was a notable direct relationship between EF and GLS (\n P<\/jats:italic>\n < 0.001,\n r<\/jats:italic>\n = \u22120.438) after 3 months and (\n P<\/jats:italic>\n < 0.001,\n r<\/jats:italic>\n = \u22120.583) after 6 months postchemotherapy. Tei Index with cutoff of 0.46 was found to have 100% sensitivity, 57% specificity, and 27.3% positive predictive value (PPV) for the prediction of cardiac dysfunction in comparison to GLS, which had 100% sensitivity, 95 specificity, and 80% PPV.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Tei Index is a good negative test for ruling out the cardiac dysfunction, but not for confirming the condition. Keep in mind, follow up should be lasted longer for further assessment of the cardiac dysfunction that may become evident at longer periods. However, our primary purpose was to look for early signs of cardiotoxicity.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jcecho.jcecho_98_25","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:00:09Z","timestamp":1788166809000},"page":"347-354","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Role of Tei Index in Early Detection of Anthracycline-induced Cardiotoxicity"],"prefix":"10.4103","volume":"36","author":[{"given":"Sara","family":"Ashraf","sequence":"first","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elamrousy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoor","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Sharafeldin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtsam","family":"Khairat","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"R1-20260831","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"R2-20260831","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1161\/CIRCULATIONAHA.107.670588","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease","volume":"115","author":"Finck","year":"2007","journal-title":"Circulation"},{"key":"R3-20260831","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamacardio.2019.2952","article-title":"Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis","volume":"4","author":"Oikonomou","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R4-20260831","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0002-9149(98)00559-1","article-title":"Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy","volume":"82","author":"Dujardin","year":"1998","journal-title":"Am J Cardiol"},{"key":"R5-20260831","first-page":"76","article-title":"Left ventricular diastolic function and cardiotoxic chemotherapy","author":"Rashid","year":"2024","journal-title":"Egypt Heart J"},{"key":"R6-20260831","first-page":"142","article-title":"Abstract 14722: The Utility of Tei Index in Subclinical Cardiotoxicity After Chemotherapy","author":"Hamamoto","year":"2020","journal-title":"Circulation"},{"key":"R7-20260831","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/jpm12020290","article-title":"Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin\u2019s Lymphoma: The Tei Index Evaluation","volume":"12","author":"Puzzovivo","year":"2022","journal-title":"J Pers Med"},{"key":"R8-20260831","article-title":"Assessment of Chemotherapy-Induced Cardiotoxicity","author":"Mujoomdar","year":"2012"},{"key":"R9-20260831","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"R10-20260831","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10554-017-1075-5","article-title":"Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis","volume":"33","author":"Liu","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"R11-20260831","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10554-012-0120-7","article-title":"Left and right ventricular strain and strain rate measurement in normal adults using velocity vector imaging: an assessment of reference values and intersystem agreement","volume":"29","author":"Fine","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"R12-20260831","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"R14-20260831","doi-asserted-by":"crossref","first-page":"32","DOI":"10.37616\/2212-5043.1296","article-title":"Role of Myocardial Strain Imaging by Echocardiography for the Early Detection of Anthracyclines-Induced Cardiotoxicity","volume":"34","author":"Selmy","year":"2022","journal-title":"J Saudi Heart Assoc"},{"key":"R15-20260831","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcmg.2019.07.018","article-title":"Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy","volume":"13","author":"Upshaw","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R16-20260831","doi-asserted-by":"crossref","first-page":"e0175544","DOI":"10.1371\/journal.pone.0175544","article-title":"Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study","volume":"12","author":"Boyd","year":"2017","journal-title":"PLoS One"},{"key":"R17-20260831","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2147\/CMAR.S166481","article-title":"Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer","volume":"10","author":"Cochera","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R18-20260831","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/echo.14252","article-title":"Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy","volume":"36","author":"Anqi","year":"2019","journal-title":"Echocardiography"},{"key":"R19-20260831","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1634\/theoncologist.2014-0500","article-title":"Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors","volume":"20","author":"Serrano","year":"2015","journal-title":"Oncologist"},{"key":"R20-20260831","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.euje.2005.04.009","article-title":"Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: Early and late alterations of left ventricular function during a prospective study","volume":"7","author":"Tassan-Mangina","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"R21-20260831","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ehjci\/jes139","article-title":"Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy","volume":"14","author":"Stoodley","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"R22-20260831","article-title":"The combined role of NT-proBNP and LV-GLS in the detection of early subtle chemotherapy-induced cardiotoxicity in breast cancer female patients","volume":"73","author":"Sulaiman","year":"2021","journal-title":"Egypt Heart"},{"key":"R23-20260831","first-page":"231","article-title":"Evaluation of the changes in Tei-index (myocardial performance index) in Doppler echocardiography before and after treating with anthracycline combinations in children with malignancy","volume":"11","author":"Naderi","year":"2021","journal-title":"Iran J Ped Hematol Oncol"},{"key":"R24-20260831","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3390\/life13102103","article-title":"Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy","volume":"13","author":"Contaldi","year":"2023","journal-title":"Life"},{"key":"R25-20260831","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00246-015-1311-5","article-title":"Early ventricular dysfunction after anthracycline chemotherapy in children","volume":"37","author":"Agha","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"R26-20260831","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/echo.13704","article-title":"Early anthracycline-induced cardiotoxicity monitored by echocardiographic Doppler parameters combined with serum hs-cTnT","volume":"34","author":"Zhang","year":"2017","journal-title":"Echocardiography"},{"key":"R27-20260831","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0894-7317(03)00110-X","article-title":"Correlation of the Tei index with invasive measurements of ventricular function in a porcine model","volume":"16","author":"LaCorte","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"R28-20260831","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0002-9149(01)01476-X","article-title":"Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children","volume":"87","author":"Eidem","journal-title":"Am J Cardiol"},{"key":"R29-20260831","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/echo.13245","article-title":"Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis","volume":"33","author":"Shaikh","year":"2016","journal-title":"Echocardiography"},{"key":"R30-20260831","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5543\/tkda.2011.01700","article-title":"Can comprehensive echocardiographic evaluation provide an advantage to predict anthracycline-induced cardiomyopathy?","volume":"39","author":"Erdo\u01e7an","year":"2011","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R31-20260831","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERP-20-0013","article-title":"The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: A systematic review","volume":"8","author":"Bennett","year":"2021","journal-title":"Echo Res Pract"},{"key":"R32-20260831","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10554-006-9145-0","article-title":"Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction. Diagnosis of adriamycin cardiotoxicity","volume":"23","author":"Rohde","year":"2007","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Journal of Cardiovascular Echography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcecho.jcecho_98_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:01:25Z","timestamp":1788181285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcecho.jcecho_98_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcecho.jcecho_98_25","relation":{},"ISSN":["2211-4122","2347-193X"],"issn-type":[{"value":"2211-4122","type":"print"},{"value":"2347-193X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}